GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kobo Biotech Ltd (BOM:531541) » Definitions » Gross-Profit-to-Asset %

Kobo Biotech (BOM:531541) Gross-Profit-to-Asset % : 0.00% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Kobo Biotech Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Kobo Biotech's annualized Gross Profit for the quarter that ended in Dec. 2023 was ₹0.00 Mil. Kobo Biotech's average Total Assets over the quarter that ended in Dec. 2023 was ₹733.37 Mil. Therefore, Kobo Biotech's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 0.00%.


Kobo Biotech Gross-Profit-to-Asset % Historical Data

The historical data trend for Kobo Biotech's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kobo Biotech Gross-Profit-to-Asset % Chart

Kobo Biotech Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Kobo Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Kobo Biotech's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Kobo Biotech's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kobo Biotech's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kobo Biotech's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Kobo Biotech's Gross-Profit-to-Asset % falls into.



Kobo Biotech Gross-Profit-to-Asset % Calculation

Kobo Biotech's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2023 )/( (Total Assets (A: Mar. 2022 )+Total Assets (A: Mar. 2023 ))/ count )
=0/( (791.852+753.3)/ 2 )
=0/772.576
=0.00 %

Kobo Biotech's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=0/( (733.366+0)/ 1 )
=0/733.366
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Kobo Biotech Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Kobo Biotech's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kobo Biotech (BOM:531541) Business Description

Traded in Other Exchanges
N/A
Address
Saki Vihar Road, Unit 104, HYDE Park, Opp. Ansa Industrial Estate, Andheri (East), Mumbai, MH, IND, 400 072
Kobo Biotech Ltd is a pharmaceutical company. Its business comprises the manufacturing and sale of APIs (Active Pharmaceutical Ingredients) based on fermentation technology and Intermediates to pharmaceutical companies.

Kobo Biotech (BOM:531541) Headlines

No Headlines